Journal: Molecular Neurodegeneration

Article Title: BIN1 protein isoforms are differentially expressed in astrocytes, neurons, and microglia: neuronal and astrocyte BIN1 are implicated in tau pathology

doi: 10.1186/s13024-020-00387-3

Figure Lengend Snippet: BIN1 expression in microglia. a RNA expression of BIN1 isoforms expressed in human primary microglia isolated from human fresh autopsy tissue. Two different batches of human microglia with n = 8 subjects on the left and n = 13 subjects on the right showed comparable results. b-e Co-immunostaining in post-mortem human brain tissue ( n = 3) with antibodies recognizing specific BIN1 exons in red (exons 7, 11, 13 or 17, which recognizes isoforms 1–9) and the microglial marker CD45 in green. Cells which express both sets of markers have a yellowish color. f Analysis of gene expression level of BIN1 (all isoforms, including isoforms 10 and 12) in monocytes and MDMi ( n = 19). No difference of gene expression level reported for CD14, a marker of myeloid cells, between two cellular models. Relative gene expression is reported on the Y-axis

Article Snippet: Six μm sections of formalin-fixed paraffin-embedded tissue from the frontal cortex ( n = 3) were used to stain for NeuN (Millipore), ALDH1L1 (eBioscience), CD45 (Novus Biological), along with anti-BIN1 antibodies provided by Biogen.

Techniques: Expressing, RNA Expression, Isolation, Immunostaining, Marker, Gene Expression

Journal: Gastric Cancer

Article Title: Bone marrow derived “fibrocytes” contribute to tumor proliferation and fibrosis in gastric cancer

doi: 10.1007/s10120-014-0380-0

Figure Lengend Snippet: Preparation of fibrocytes. Crude fibrocyte preparations derived from PBMCs were depleted of contaminating T cells, B cells, and monocytes by immunomagnetic negative selection. The cells were stained with monoclonal mouse-anti human CD45 conjugated to phycoerythrin (PE) and monoclonal anti-human COLA-IA conjugated to fluorescein isothiocyanate (FITC) and analyzed by flow cytometry

Article Snippet: To determine the purity of these fibrocyte preparations, the cells (5 × 10 5 /100 μL) were incubated in the dark for 30 min at 4 °C with a monoclonal mouse-anti human CD45 antibody conjugated to phycoerythrin (PE; BD Biosciences, San Diego, CA, USA) and a mouse anti-collagen type I antibody conjugated to fluorescein isothiocyanate (FITC; Rockland, Inc., Gilbertsville, PA, USA).

Techniques: Derivative Assay, Selection, Staining, Flow Cytometry

Journal: Science Advances

Article Title: Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration

doi: 10.1126/sciadv.add1101

Figure Lengend Snippet: ( A ) Representative dot plots showing CD45 int CD11b + microglia with AF low (AF lo ) and AF high (AF hi ) properties in young and old mice, respectively. ( B ) Microglia counts in young and old brain hemispheres, including for each AF subset, are shown. ( C ) The level of AF in each bulk microglial population and subset is quantified using the mean fluorescence intensity (MFI) of the empty fluorescein isothiocyanate (FITC) channel. Representative histograms are shown next to the relative MFI quantification of ( D ) lipid content, ( E ) lipid peroxidation levels, and ( F ) iron accumulation in microglia as demonstrated using fluorogenic dyes. Phagocytic activity was measured by ( G ) intracellular detection of the neuronal marker MAP2, ( H ) fluorescence of neuronal SLICK-YFP (single-neuron labeling with inducible Cre-mediated knockout–yellow fluorescent protein) reporter mice, and ( I ) intracellular detection of the myelin marker, myelin CNPase. ( J and K ) Oxidative stress was measured by intracellular protein expression of NOX2 and production of ROS using dihydrorhodamine (DHR) 123. N = 5 per group. Fluorescence minus one (FMO) controls are shown in gray, while microglial populations are color-coded according to bar graph. A vertical fiducial line is included for reference. AF, autofluorescence; Max, maximum; Ox, oxidation; Red, reduction; SSC, side scatter; ns, not significant. Nonparametric data were analyzed using Mann-Whitney test (* P < 0.05 and ** P < 0.01).

Article Snippet: Surface antibody cocktails were prepared with CD45/PerCP-Cy5.5 (1:100; BioLegend) and CD11b/APC-Fire 750 (1:100; BioLegend) including viability dye Zombie Aqua.

Techniques: Fluorescence, Activity Assay, Marker, Labeling, Knock-Out, Expressing, MANN-WHITNEY

Journal: Science Advances

Article Title: Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration

doi: 10.1126/sciadv.add1101

Figure Lengend Snippet: ( A ) Representative dot plots show the immune profile in the brains of young and middle-aged Apoe , h APOE3 , and h APOE4 , quantified on the right. Representative histograms depict the relative level of cell granularity ( B ), autofluorescence ( C ), lipid accumulation ( D ), CD68 ( E ), and Lamp1 ( F ) protein expression and intracellular cytokine production of TNF ( G ) in CD45 int CD11b + microglia across ages and genotypes. ( H ) Ex vivo neuronal engulfment assay shows a significant increase in the percent of microglia that phagocytized live SLICK-YFP neurons, quantified on the right. Validation of internalized myelinated cortical neurons was performed using intracellular detection of anti-YFP ( I ) and anti-myelin CNPase ( J ) in phagocytic (SLICK-YFP + ) and nonphagocytic (SLICK-YFP − ) microglial populations within the same brain. N = 6 to 7 per group. MA, middle-aged; Y, young; ns, not significant.. Data were analyzed using one-way analysis of variance (ANOVA) with Bonferroni post hoc correction for multiple comparisons (* P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001).

Article Snippet: Surface antibody cocktails were prepared with CD45/PerCP-Cy5.5 (1:100; BioLegend) and CD11b/APC-Fire 750 (1:100; BioLegend) including viability dye Zombie Aqua.

Techniques: Expressing, Ex Vivo

Journal: Science Advances

Article Title: Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration

doi: 10.1126/sciadv.add1101

Figure Lengend Snippet: ( A ) Timeline of experimental design immediately before sham and TBI surgery. ( B ) Representative dot plots of immune populations in the ipsilateral brain hemisphere at 3 days after TBI. Quantification of CD45 int CD11b + microglia and CD45 hi CD11b + -infiltrating myeloid cell counts per hemisphere are shown for aged, surgery, and treatment groups. ( C ) A representative histogram of DHR123 + microglia is shown next to the relative MFI quantification of ROS production. In the associated histogram, young groups are shown with no outline, old groups are shown with bold outlines, and treatment groups are color-coded according to bar graph and figure legend (Veh in red and PLX5622 in blue). A vertical fiducial line is included for reference. Representative dot plots depicting ( D ) IL-1β production and ( E ) p16 expression in microglia are shown next to quantification of cell frequencies. ( F ) Cytokine protein concentrations in the peri-lesional cortex as measured by ELISA. No differences were seen between sham control groups after treatment, and so data for both sham groups were combined. For all cytokines (M-CSF, G-CSF, eotaxin, IL-1a, MIG, and MIP-2), TBI acutely increased concentrations in Veh but not PLX5622-treated groups. N = 3 to 4 per sham and 6 to 7 per TBI group. ns, not significant. Data were analyzed using two-way ANOVA with Tukey post hoc correction (B to E) and one-way ANOVA with Bonferroni post hoc correction (F) for multiple comparisons (* P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001).

Article Snippet: Surface antibody cocktails were prepared with CD45/PerCP-Cy5.5 (1:100; BioLegend) and CD11b/APC-Fire 750 (1:100; BioLegend) including viability dye Zombie Aqua.

Techniques: Expressing, Enzyme-linked Immunosorbent Assay

Journal: Science Advances

Article Title: Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration

doi: 10.1126/sciadv.add1101

Figure Lengend Snippet: ( A ) Timeline of experimental design immediately before sham and TBI surgery. ( B ) Representative dot plots of immune populations in the ipsilateral and contralateral (internal control) brain hemispheres at 2 weeks after TBI. Quantification of CD45 int CD11b + microglia (left), infiltrating CD45 hi CD11b + myeloid (center), and CD45 hi CD11b − lymphocyte (right) counts per hemisphere is shown for aged, injury, and treatment groups. ( C ) A representative histogram of CD68 + microglia is shown next to the MFI quantification of this phagocytosis marker. ( D ) A representative histogram shows the relative level of neutral lipids in microglia from each hemisphere after TBI. ( E ) Representative dot plots depict the percentage of Lipi-Blue+ microglia after TBI. The frequency of lipid droplet–containing microglia is quantified. ( F ) A representative histogram shows the relative level of ROS production in microglia as measured by DCF probe. ( G ) Cytokine protein concentrations in the peri-lesional cortex as measured by ELISA. No differences were seen between sham control groups after treatment, and so data for both sham groups were combined. N = 3 to 4 per contralateral and 6 to 7 per ipsilateral (i.e., TBI) group. FMO controls are shown in gray, contralateral groups are shown with no outline, ipsilateral groups are shown with bold outlines, and treatment groups are color-coded according to bar graph and figure legend (TBI + Veh in red and TBI + PLX5622 in blue). Contra, contralateral; Ipsi, ipsilateral; ns, not significant.. Data were analyzed using two-way ANOVA with Tukey post hoc correction (B to F) and one-way ANOVA with Bonferroni post hoc correction (G) for multiple comparisons (* P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001).

Article Snippet: Surface antibody cocktails were prepared with CD45/PerCP-Cy5.5 (1:100; BioLegend) and CD11b/APC-Fire 750 (1:100; BioLegend) including viability dye Zombie Aqua.

Techniques: Marker, Enzyme-linked Immunosorbent Assay